Clinical trials
Phase 2 Carcinoma, Transitional Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 12 |
| 2018 | 11 |
| 2019 | 9 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 23 |
| Active, not recruiting | 19 |
| Recruiting | 15 |
| Withdrawn | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| M.D. Anderson Cancer Center | 7 |
| Memorial Sloan Kettering Cancer Center | 6 |
| Fox Chase Cancer Center | 4 |
| Matthew Galsky | 4 |
| Incyte Corporation | 3 |
| University of Michigan Rogel Cancer Center | 3 |
| Achieve Life Sciences | 2 |
| Bristol-Myers Squibb | 2 |
| Mayo Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 101 |
| Urinary Bladder Neoplasms | 44 |
| Ureteral Neoplasms | 10 |
| Urethral Neoplasms | 10 |
| Carcinoma, Renal Cell | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasm Metastasis | 7 |
| Colorectal Neoplasms | 6 |
| Melanoma | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.